Inotiv (NOTVQ) Capital Expenditures Growth (1y) (2011 - 2026)
Inotiv (NOTVQ) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 8.47% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -27.73% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 31.13% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 1.48% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 16.40% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 27.78% |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | -61.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.58% |
| Dec 31, 2025 | 16.17% |
| Sep 30, 2025 | -49.44% |
| Jun 30, 2025 | -9.39% |
| Mar 31, 2025 | -22.06% |
| Dec 31, 2024 | -19.97% |
| Sep 30, 2024 | -14.31% |
| Jun 30, 2024 | -1.40% |
| Mar 31, 2024 | -17.11% |
| Dec 31, 2023 | -33.42% |
| Sep 30, 2023 | 22.97% |
| Jun 30, 2023 | -72.10% |
| Mar 31, 2023 | -11.27% |
| Dec 31, 2022 | 47.99% |
| Sep 30, 2022 | 22.14% |
| Jun 30, 2022 | 171.00% |
| Mar 31, 2022 | 901.78% |
| Dec 31, 2021 | 283.65% |
| Sep 30, 2021 | 271.97% |
| Jun 30, 2021 | 240.28% |